MAPT and neuroblastoma: In addition, pepstatin A (PEPA) alone and E64D plus PEPA (E64D + PEPA), autophagy inhibitors, significantly inhibited Tau degradation (Fig. 7c), suggesting that ALS was the major pathway of UBE4B and STUB1-mediated Tau degradation in neuroblastoma cells.